Prestige officially acquires 15-of-17 GSK legacy brands
IRVINGTON, N.Y. — Prestige Brands on Tuesday announced that it has completed its previously announced purchase of 15-of-the-17 brands it agreed to acquire from GlaxoSmithKline.
Prestige did not identify the two brand acquisitions not yet completed.
The former GSK brands represent approximately $200 million in annual revenues, which is projected to push Prestige annual revenues above $600 million, Prestige stated in an investor presentation in December.
Among the brands the company agreed to acquire in December are the BC, Goody's, Stanback and Ecotrin brands of pain relievers; Beano, Gaviscon, Phazyme, Tagamet and Fiber Choice gastrointestinal brands; the Chap-et lip balm; the Debrox earwax removal brand; the Massengill feminine hygiene product; the antiseptic oral cleanser Gly-Oxide; R&C Shampoo; the pediculicide Kwellada-P; and the Sominex and Nytol sleep aid brands.